. 2024 Oct 9;11:1460372. doi: 10.3389/fmed.2024.1460372
Copyright © 2024 Kashani, Karimi, Sharifi Rayeni, Azizi Nadian, Mortezazadeh, Parsaei, Abolghasemi, Shirsalimi, Mofidi and Seyyed Mahmoudi.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Figure 1.
Flowchart of included patients with recurrent HCV with DAA treatment regimens.